Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patients.
Duarte-Millán MA, Mesa-Plaza N, Guerrero-Santillán M, Morales-Ortega A, Bernal-Bello D, Farfán-Sedano AI, García de Viedma-García V, Velázquez-Ríos L, Frutos-Pérez B, De Ancos-Aracil CL, Soria Fernández-Llamazares G, Toledano-Macías M, Cristóbal-Bilbao R, Luquín-Ciuro N, Marrero-Francés J, Piedrabuena-García SI, Satué-Bartolomé JA, Gonzalo-Pascua S, Rivilla-Jiménez M, Carpintero-García L, Ayala-Larrañaga I, García-Bermúdez V, Lara-Montes C, Llerena-Riofrío ÁR, RIvas-Prado L, Walter S, Escriba-Barcena A, San Martín López JV, Ruíz-Giardín JM. Duarte-Millán MA, et al. J Med Virol. 2022 Apr;94(4):1540-1549. doi: 10.1002/jmv.27488. Epub 2021 Dec 7. J Med Virol. 2022. PMID: 34845754 Free PMC article.
[Snowman sign].
Rueda-Camino JA, Castro-Gordon A, Duarte-Millán MA, Bernal-Bello D. Rueda-Camino JA, et al. Rev Med Interne. 2016 Apr;37(4):296-7. doi: 10.1016/j.revmed.2015.06.018. Epub 2015 Jul 21. Rev Med Interne. 2016. PMID: 26205196 French. No abstract available.
[An unexpected cause of increased volume of the abdomen].
Duarte-Millán MA, Frutos-Pérez B, Cueto-Callejón M, Rueda-Camino JA, Ruiz-Ruiz J, Zapatero-Gaviria A. Duarte-Millán MA, et al. Rev Med Interne. 2016 Nov;37(11):785-786. doi: 10.1016/j.revmed.2016.06.004. Epub 2016 Jul 9. Rev Med Interne. 2016. PMID: 27402386 French. No abstract available.
High doses of systemic corticosteroids in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. A cohort study.
Rueda-Camino JA, Bernal-Bello D, Canora-Lebrato J, Velázquez-Ríos L, García de Viedma-García V, Guerrero-Santillán M, Duarte-Millán MA, Cristóbal-Bilbao R, Zapatero-Gaviria A. Rueda-Camino JA, et al. Rev Clin Esp (Barc). 2017 Dec;217(9):504-509. doi: 10.1016/j.rce.2017.07.012. Epub 2017 Aug 31. Rev Clin Esp (Barc). 2017. PMID: 28865758 English, Spanish.
Imatinib for COVID-19: A case report.
Morales-Ortega A, Bernal-Bello D, Llarena-Barroso C, Frutos-Pérez B, Duarte-Millán MÁ, García de Viedma-García V, Farfán-Sedano AI, Canalejo-Castrillero E, Ruiz-Giardín JM, Ruiz-Ruiz J, San Martín-López JV. Morales-Ortega A, et al. Among authors: duarte millan ma. Clin Immunol. 2020 Sep;218:108518. doi: 10.1016/j.clim.2020.108518. Epub 2020 Jun 27. Clin Immunol. 2020. PMID: 32599278 Free PMC article. No abstract available.
Early clinical experience with imatinib in COVID-19: Searching for a dual effect.
Morales-Ortega A, Rivas-Prado L, Frutos-Pérez B, Jaenes-Barrios B, Farfán-Sedano AI, García-Parra CJ, Hernández-Muniesa B, Duarte-Millán MÁ, Madroñal-Cerezo E, Ontañón-Nasarre A, Ruiz-Giardín JM, Bermejo F, García-Gil M, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D. Morales-Ortega A, et al. Among authors: duarte millan ma. J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2021.02.002. Epub 2021 Feb 5. J Infect. 2021. PMID: 33549625 Free PMC article.
Lung cavitation in granulomatosis with polyangiitis: clinical implications.
Bernal-Bello D, Morales-Ortega A, Duarte-Millán MÁ, Tardío JC, Frutos-Pérez B. Bernal-Bello D, et al. Among authors: duarte millan ma. Clin Rheumatol. 2022 Sep;41(9):2915-2916. doi: 10.1007/s10067-022-06243-7. Epub 2022 Jun 16. Clin Rheumatol. 2022. PMID: 35705728 No abstract available.
Baricitinib or imatinib in hospitalized COVID-19 patients: Results from COVINIB, an exploratory randomized clinical trial.
Morales-Ortega A, Farfán-Sedano AI, San Martín-López JV, Escribá-Bárcena A, Jaenes-Barrios B, Madroñal-Cerezo E, Llarena-Barroso C, Mesa-Plaza N, Frutos-Pérez B, Ruiz-Giardín JM, Duarte-Millán MÁ, Piedrabuena-García SI, Carpintero-García L, Canalejo-Castrillero E, Mora-Hernández B, García-Parra CJ, Magro-García HA, Algaba-García A, Hernández-Muniesa B, Nasarre-López B, Ontañón-Nasarre A, Domínguez-García MJ, Gómez-Santos D, Prieto-Menchero S, García de Tena J, Bermejo F, García-Gil M, Gonzalo-Pascua S, Bernal-Bello D; COVINIB Study Group investigators. Morales-Ortega A, et al. Among authors: duarte millan ma. J Med Virol. 2023 Feb;95(2):e28495. doi: 10.1002/jmv.28495. J Med Virol. 2023. PMID: 36639911 Clinical Trial.
15 results